| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |